-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GNvli7uG5PY+54RZTC/Xkn6kIG/p48mwe4ZtO3Z+3p305FecIhd+zhlBaV70ZFWe jiFJKbiYIJ08gzNAfMO2dQ== 0000950123-10-064567.txt : 20100709 0000950123-10-064567.hdr.sgml : 20100709 20100709135616 ACCESSION NUMBER: 0000950123-10-064567 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100709 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100709 DATE AS OF CHANGE: 20100709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN PHYSICIANS CAPITAL INC CENTRAL INDEX KEY: 0001118148 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 383543910 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-32057 FILM NUMBER: 10945995 BUSINESS ADDRESS: STREET 1: 1301 NORTH HAGADORN ROAD CITY: EAST LANSING STATE: MI ZIP: 48823 BUSINESS PHONE: 5173511150 MAIL ADDRESS: STREET 1: 1301 NORTH HAGADORN ROAD CITY: EAST LANSING STATE: MI ZIP: 48823 8-K 1 k49417e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 9, 2010
AMERICAN PHYSICIANS CAPITAL, INC.
(Exact Name of Registrant as Specified in its Charter)
Commission File Number 000-32057
     
Michigan   38-3543910
(State of Incorporation)   (IRS Employer Identification No.)
1301 North Hagadorn Road, East Lansing, Michigan 48823
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code): (517) 351-1150
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01   Other Events.
On July 9, 2010, American Physicians Capital, Inc. issued a press release regarding future dividends and share repurchases. A copy of the release is attached as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01   Financial Statements and Exhibits.
(c) Exhibits.
         
  99.1    
Press Release dated July 9, 2010
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
July 9, 2010
         
  AMERICAN PHYSICIANS CAPITAL, INC.
(Registrant)
 
 
  By:   /s/ Frank H. Freund    
    Frank H. Freund   
    Executive Vice President, Treasurer and Chief Financial Officer   
 

 

EX-99.1 2 k49417exv99w1.htm EX-99.1 exv99w1
Exhibit 99.1
(LOGO)
     
For Immediate Release
  Contact: Ann Storberg, Investor Relations
(517) 324-6629
AMERICAN PHYSICIANS CAPITAL, INC. TO DISCONTINUE QUARTERLY CASH
DIVIDEND AND SHARE REPURCHASE PROGRAM
East Lansing, Mich. (July 9, 2010) — American Physicians Capital, Inc. (APCapital) (NASDAQ:ACAP) announced yesterday in a press release that it has entered into a definitive agreement pursuant to which The Doctors Company will acquire APCapital for $41.50 per share in cash. The press release and the definitive merger agreement were filed with the U. S. Securities and Exchange Commission as exhibits to APCapital’s Form 8-K. The terms of the merger agreement prohibit APCapital from paying dividends or repurchasing its shares without the prior consent of The Doctors Company. APCapital currently does not intend to seek permission to pay any further cash dividends to its shareholders or to continue its share repurchase program.
About American Physicians Capital Inc.
American Physicians Capital, Inc. is a regional provider of medical professional liability insurance focused primarily in the Midwest and New Mexico markets through American Physicians Assurance Corporation and its other subsidiaries. Further information about the companies is available on the Internet at http://www.apcapital.com.
###

GRAPHIC 3 k49417k4941700.gif GRAPHIC begin 644 k49417k4941700.gif M1TE&.#EAZ0!:`/<```````L+"Q(2$A@8&!\A(BLN,#,X/3$[1A]#:1%'?Q5& M>5-E>5QG=6)K=6=N=FQT?0-(CP1)CPY'@PI(B0-(D!E1CB97CC-#GZ^+I[>?M M\.KO\>SQ\^_S]/+U]O7W]____P```#X`/!+9<,H```$``SH`0U<`7$X`24\` M1%,`5W,`7',`>64`=#,`;5P`,G,`36T`:68`=&0`+FP`;``````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````!+;>!A-L)-T\A+;7!E'R````!4``)0`&@`"?=T` M&0`"?````````1E#(````!A3(!+)%B!@```90'-9%AS@```````!E'R!8`/)?NR``````` M``@``)?LP)?NR!+A;!+A;)0'-1+<`!+A9AE'R``````!-1+<-)#V7)#V80`! M-0```!E'R!+<$)%?L!+<>)#I(``!-0``?A+<1("3GA+A+!+A,````!+<>)#V M7)#V80```!+A,!+A+!+<5!E'R!+@_)#I(```````?A+5-E>5QG=6)K=6=N=FQT?0-(CP1)CPY' M@PI(B0-(D!E1CB97CC-#GZ^+I[>?M\.KO\>SQ\^_S]/+U]O7W]____P```#X` M/!+9<,H```$``SH`0U<`7$X`24\`1%,`5W,`7',`>64`=#,`;5P`,G,`36T` M:68`=&0`+FP`;``````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````````````!+;>!A-L)-T M\A+;7!E'R````!4``)0`&@`"?=T`&0`"?````````1E#(````!A3(!+)%B!@```90'-9%A MS@```````!E'R!8`/)?NR`````````@``)?LP)?NR!+A;!+A;)0'-1+<`!+A M9AE'R``````!-1+<-)#V7)#V80`!-0```!E'R!+<$)%?L!+<>)#I(``!-0`` M?A+<1("3GA+A+!+A,````!+<>)#V7)#V80```!+A,!+A+!+<5!E'R!+@_)#I M(```````?A+JT((BP6RE4\'JVKMVA*3*HW3L7 MX=N]%"#T!7JWL&&4>=7&7>NA[8>P>[=6^-#VL.7+$M,"!MQ7((O'F]5VQDRZ M]$(5>D-S;ND!\N+%24>;GCT;A0;5@"%`N)"B->[`<>>*K$R[>%T5MW]SU7UA MA&_EHL<:GWX7^6_=:IMW@`R=ZV3JX,O^IDB.&[;VJ+"!A\8NEW+X]T3'=^=Z M(80&[NFA?V\*O[]*ZZKE5U\'$VPV07ZX34:A%R!FR'8G$=);177!/?- M%YMT#79XD7S*+59?4V"EUT$)H"$8VGX>MAC1@QJ.Z!E87&&(@@LI@`9=<""X MZ&-#R+FF7'TJ$,0"C11H<*-GK:FXW&(L_BBED1E`.)][`P&E`@@7*%F0"CK. M%^644K*@`81.*G9!"96IT`$)!['@@977!5;!"&3F20)Y\ZWIU&==%FD0"=R% MN&:>>9;`9W>'#@1:!1H(.I!M&E(@(Z)D*EJII24(%":DDIZ087>[A;`@IAZR ML&>E$FA`0HK^P47J@JB%_G8IJGHN>IT$%R`5604@V%8K;K?BFJN&*D*@P0AG MQFBJL;BNNNE>&MA'YY#/0AMML],F:=^PJM5WJK92[IFF:M7>]YJMV9)K[)[7 M*IAV2B+&X6+9T&WKW0=&4`(%?L!RZ,O<`^[BDPE4H`,55(CDDG(!_"U$ M!!LP0.J8%[$1&"!HXS/`1E@`OMOI$"+^(M@?`!Q8$!'(4(((=-01,U<`_R%$ M!`^P70,*8Y_Y/:2$+51<0:B'.AINP(:6>P`+?I@1$80P?'AZR!A31\2";.", M`"@`V(R(N@)L8%PGR$`(&5`85='O*3PCB'T^(*F)$*"+`SF9"/AXP0],42,9 M8"(;(Y(\U+712#T<71M+4$G771(A)VA`YOA8'!9\[Y$#&8$6#Y+)K1%$9@(Q MASG2F)$C%D"4J".C0R*HR83@C'YP/[D"!%SD*XX)3@B,SGB3.9YYF4?P)Y& MO@F``%#&F4/^U.8D$?*!U`4`3VNT9$1*`#Y=DD:86EOG1MI)DX`6@"0&S*7B MMJFU;@I$!+?[W!M11P#R(424!3`)"SB($046A`7F:)U"-<+0F513:X_DXN@$ M0$N&4#2?_,RH"VZ*2B#B32$G4.`(3C"P$WP@`[T[J0+9M)`3P/!F!#G9(3.W M4H2P0*A,54A+94)/`$A';/MLR$TMZH*N9BX`'10B69N:PD1^<&@,8$`#,A"] M.#T5:P!`I=4RH+W=N=!J#\!K2"\:Q5S"$YXL8P$,X2I7NLK3(%M5200?.I!? M4O4A8TU(1$=7`-KYTZ,1<236SBB`6U+L,[QKY10_<[[TF:."BI7^&.:T-E@7 M-`".`'C=VG:+/1%DP``$.&,`"-`[XD06):?+*T'ZF4VQAO6D2QRE;5-76XS0 MS@#H*X!"<+2G"]AK4(ML(+T"V`!)Z-C=-%H6F/K#W>T2["GEU?9R MSBQMV]IF`*-F,@"Q*]\V"3!-%^#7)!$40%L?#("J(B2S76/O`5AP@O1*-R/\ M/:ZCHK9&6\HLYBQH)-QK"!S;TR0$W.DQEHC MY7*M!]J=/KH(]&XFT;;7R1J9\1Z`8.KF]M&GJG@>SWU+7@8C.G)DK8E8"M''-JH.M M,RW=EDBB3J$4K6[Y_%S$F9K9=NXMB*`U\LO=R?+5YJ`S`+2LD)OFUFYCLYYW M!4+F1<_SU@R8)4$PG5N?07G6<?UH@1#==6OJ'NGP2AZ*0%PNS,R;/><73VZ/A< MN+H:29S_%8BV+S)EY1E\K0*Y*0/X&M<#.%RNAYL=/D5=$<6.Q+?.3/5`Y/U$ M.!(1WZ+6\[[^G]*6V++WD@.W""X#L-N6[Q:?M'YQ6&E\`J(JY-BY;:M&4.1H M?SZ6XP=!-S<'`G)]7S:!'X1O`U6-2)3PD'0BB+K4IVY6U7D4QA#!M]9*3$W9 MTI:\&D]X>!/B3`(6'=K//DC$&L!=`G`WT0-).46P"8`D%J0$LD8XUA]"]S1O MA&\85-T!>/;NGX\=(>3].)[1/O(X.7*J+)_E_E#>])-X.NPR1UW,#;)WASR= MHSIO2,0X5()8NVY\1BY\O`]_$/)RZ.RI3#OG,BD^[$V>Z:-S)T<"6KJ%5!T` M!`C]QK_L$*WC%"*F?-UP].@ZYA$;\T!OO019!GN!B/SH;FS=!(/^!Z!*"R(2 M1J4\#:!*#_1[N?4!PM<0&X!/`E!M;352;%AG`O%@"38"$2-$=T-*%#6*-95' MGL1Y[P8V#T89'E8`^!8`=WB*3.0W(E$"<$2&$L&*0>-,C-86$1,S[$55AQ-; M$78[311/T_-CW94!\11U24=:+"-3KN,WPR5$+282ML8`&U0"OB4Z`H!`(Q6) M,S14.P9,07-(";8_`>!P9"-K<11UFY4Y),:*JU00-V-PF3--QJ<\9TB./E01 M)=``P46-K-.0!*%TJ6-I#\9RV&-K078YN--$131D_@0[B81/JL,UMS5A.D-= M'Q!8RB,`#D?^@!%Q,W!3DV5#@"EEDSHI/GBWDS998*%U.8%S.X)#`$;Y-N)G M??2%/G/C74F8-7,SB1/H.H#3;8,C0!;DDV2C4`=&6O8U*PP0D?546KYS`GC5 ME&-!7UHI`%SW$"^C,G`9EW,4EW0)EW>$,G5)EPCG$'>U81Q6..:PC1\DDX"W M-L'&,B+`=KV30A3%`(O55WE#'`:3ERES23&T80:@B$9B.6MS`)II?6QW`.:@ M,4%#F2FC?A:1`BE@%UJB`H2!(R6PFDVUB!PTD!(1?2=E:"4E`DRE`I]H%V[B M)6:!(AW0`1[P`2%0`BC0`1?`$YYA54.!FP*A`B40`E''02B@@EG^5(AX7D3(9W+V27%J0&] M`B<)P80",2>\@1F?$147,)#GN1`IH``74"3C>0$D()^O&2=$@9OC,37#T0$* M$`)JE#BSTRNR:6@)ZG3->0$5X)^^R0(J@`(WP@(I<`*"XJ(LVA0GP*(IL*(Q MRJ)$Q0(LZIHK2G/921`I4`$-*A`7L*'RN:+9J0*J*1),>J,L"A11*J7*F0(H ML*-7ZIHT!J4SVA16&J0%$7URH@`@$13(T2,JH*4JJJ4QNIJH\2Q,6B0LT"N" M,IC_.:(502@AT`$[437WX0'O&0(?P)_^D2(G&G"H)<"1T*H M)^`!O>(!H2HK]H&J)2:F)BJ;69*FB6J<8*(!Q_FI'02J*.`!GMH!D=H!KFFB M@H*LIG*C-.H"2LJK0L$"VP&HO)("BL(K+[.IZ;*AK1$"C/,1[4FHK5("75(" M7,*?>W*B9Y(!(``6%R"D1%H">^*I)9``S>D3]=$KG?(8`#M("2`\%Y`!).`3 M]U$!ZNH!G>H!;W%"^:I*ZUJRMF[KLT7:J=NA`:\Y MI!I`M9`2GS&JHKXE`4\[%E(KHC=;2'S;`7Y;`2B`J6NR)NK*KZ4ZN@E@N2)A MHBI:`G,2*;WB*1MZ)!?`*_[I?>\WG>29O,^9IBK`N?OJG'P[J('^JZ$A2[4FRK)>R[$'"K0*T+)3JYJ0(KJ'F@`: MLR5=D@&HR[.JVRM!T;H/I+5FHK@NH*&H6C6]8:)'JP$)0`(BRL#\R9X:P+&; M`ZTN8`++2:3XXF[OIF"NJ0%K&Q2J8IPI(P$GHK55LZ&DB[TJ`+,9P+TI"[\H M8#6="K;F]9PVH;?98B8HC,$>,:`>D`#6ZP'J*#R0(A(H0+;I^JYKXL![*@%C ML<2\01C[RK##X0+;"[MG>R/C*0$]D@$A\,(G6@'RJJ_@ZQ-SH0!,VRKTZII\ M.L:Q8R;OZV.X54_>I:[EJ:8+X\`?0`+^&#("B+O`X[&[0PP"R&K$!:NN!JS% M*VLUV-HJC\$F)X":*M$K"I`!C8$"H6I"1[HFVW%"C".R(4ND!K.I'E#(HDJD MJ]PK_%H!_'HQ"E"_+L`E"9#)_ND1_+JGX'HC]Y$"=#S!\3D7&MHKQ5D!#,K* MF[K,'6#+_PJRV<)B$O1(BN*IQ_F>R,J?)G0?&,*?BWB\RKK,!7LF1(K*`J&A M\UK!+)"J'*L!(K`L0M%!RBFG+*J<-;RD->R:+)J=(S4"16*E)5`D^[R:*#`" M05J;(@#07(H"LJFD\^P9]_R[RMD4G\IK*4`"V?FE!&W0O\O0E>R;&-U!^MRC M-4H"UCI`L)9RTH$);<5IG"'0-!^@K!^@R)_Z`3?B-<=Y)"<"`LK*TR%PG!Q: M/B%``CQ](P6-(]*$IQDQH?29FT;B>4KM&26``37;%(H3U7^2)2_QNG'R)TQM C&5^]0Y41UCI\IPKQ&)[K$KMG$5D]$!&:OA43UW(]$`$!`#L_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----